Dopamine β-Hydroxylase
Dopamine β-hydroxylase [DBH; dopamine β-monooxygenase; EC l.14.17.1 3, 4-dihydroxyphenylethylamine; ascorbate: oxygen oxidoreductase (hydroxylation)] is a copper-containing monooxygenase that catalyzes hydroxylation of a phenylethylamine (mainly dopamine in vivo) at the β-C of the side chain to a phenylethanolamine [noradrenaline (NA) from dopamine], using molecular oxygen and ascorbic acid as an electron donor. DBH localizes in noradrenergic and adrenergic neurons of the brain, in noradrenergic neurons of peripheral sympathetic nerves, and in NA and adrenaline (A) cells of the adrenal medulla, and synthesizes NA and A, which are important neurotransmitters and hormones (Nagatsu, 1973 ) (Fig. 1 ).
- Acquisition of Drug Self-Administration
- Production of Antisera Using Peptide Conjugates
- Animal Models of Sugar and Fat Bingeing: Relationship to Food Addiction and Increased Body Weight
- Imaging cAMP Dynamics in the Drosophila Brain with the Genetically Encoded Sensor Epac1-Camps
- The Cut-Off Behavioral Criteria Method: Modeling Clinical Diagnostic Criteria in Animal Studies of PTSD
- Regulation of Dopamine Transporter Expression by Neuronal Activity
- Culturing Mouse Cerebellar Granule Neurons
- Visualization and Quantitation of Neurotrophin mRNAs
- Radioreceptor Assays for Amino Acids and Related Compounds
- Neurite Outgrowth Assessment Using High Content Analysis Methodology